Differences in Endothelial Function Amongst Sitagliptin and Liraglutide Users

NCT01785043 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

DIABETES Mellitus Type 2 Not Well Controlled

Interventions

DRUG: Liraglutide
DRUG: Sitagliptin

Sponsor

Anna Cruceta